Upload
olalekan-tella
View
232
Download
0
Embed Size (px)
8/3/2019 DVT-Dr Tella (Seminar on DVT)
1/29
SEMINAR ON DEEP VEINSEMINAR ON DEEP VEIN
THROMBOSIS (DVT)THROMBOSIS (DVT)NATIONAL ORTHOPAEDIC
HOSPITAL,DALA-KANOTHURSDAY, 2ND FEB, 2012
8/3/2019 DVT-Dr Tella (Seminar on DVT)
2/29
NonNon--pharmacologicalpharmacologicalprophylaxis of Deepprophylaxis of Deep
Vein ThrombosisVein Thrombosis(DVT)(DVT)
Dr Tella A.O.NOH, Dala-Kano
8/3/2019 DVT-Dr Tella (Seminar on DVT)
3/29
OutlineOutline
Introduction- Scope of the problem
Rationale for prophylaxisRisk assessment/stratification
Methods of prophylaxis
- Non-pharmacological- pharmacological
Challenges of DVT prophylaxis
Conclusion
8/3/2019 DVT-Dr Tella (Seminar on DVT)
4/29
IntroductionIntroduction
--Possible clinical scenariosPossible clinical scenariosAsymptomatic DVT
Symptomatic DVT
Pulmonary Embolism
Chronic pulm. hypertension
Post-phlebitic Syndrome
8/3/2019 DVT-Dr Tella (Seminar on DVT)
5/29
IntroductionIntroduction
8/3/2019 DVT-Dr Tella (Seminar on DVT)
6/29
Rationale for prophylaxisRationale for prophylaxis
High prevalence of DVT- Usually clinically silent
- Screening for DVT is neither effectivenor cost-effective
Adverse consequences of DVT- Symptomatic DVT and fatal PE
- Increased future risk of recurrent DVT- Risks and costs of DVT Rx is more thanprophylaxis costs
8/3/2019 DVT-Dr Tella (Seminar on DVT)
7/29
Rationale for prophylaxisRationale for prophylaxis
Efficacy and effectiveness ofprophylaxis:
- Prophylaxis against DVT is effective
- The prevention of DVT also prevents
PE
- DVT prophylaxis is cost-effective
8/3/2019 DVT-Dr Tella (Seminar on DVT)
8/29
RiskRisk
assessment/stratificationassessment/stratificationLOW RISK:- Minor surgery 30 min; 40 yrs; No other riskfactors
- Major medical illness: Heart/Lung diseases- Major trauma/Burns- Minor surgery, trauma, medical illness in pxswith previous DVT, PE or Thrombophilia.
8/3/2019 DVT-Dr Tella (Seminar on DVT)
9/29
RiskRisk
assessment/stratificationassessment/stratificationHIGH RISK:- Major orthopaedic surgery
- # pelvis, hip, lower limb- Major surgery, trauma, medical illnessin a px with hx of DVT, PE orThrombophilia
- Limb paralysis (e.g stroke, paraplegia)- Major LL amputation
8/3/2019 DVT-Dr Tella (Seminar on DVT)
10/29
Methods of prophylaxisMethods of prophylaxis
Non-pharmacological (Mechanical):
- General
- Specific
Pharmacological (chemical)
8/3/2019 DVT-Dr Tella (Seminar on DVT)
11/29
Methods of prophylaxisMethods of prophylaxis
General:- Patients should spend as littletime as possible waiting for surgery- Deep breathing exercises- Active and frequent exercises of
the limbs- Regional anaesthesia- Surgical technique- Early ambulation of patients
8/3/2019 DVT-Dr Tella (Seminar on DVT)
12/29
Early ambulationEarly ambulation
Early ambulation remainsthe most important non-
pharmacologic methodShould be routine part ofall post-op care (Unlessabsolutely contraindicated)
Acceptable as DVTprophylaxis for low risksurgical patients
8/3/2019 DVT-Dr Tella (Seminar on DVT)
13/29
Specific MechanicalSpecific Mechanical
DevicesDevicesGraduated Elastic Stockings- Thigh-high- Calf-highIntermittent pneumatic CompressionDevices
- Pneumatic Compression Devices(PCDs)- Sequential Compression Devices
(SCDs)
8/3/2019 DVT-Dr Tella (Seminar on DVT)
14/29
MechanismMechanism
Decreased venous stasis
- increase venous velocity
- increase venous volume
Inhibits coagulation cascade
- tissue factor (plasminogen)
- factor VIIa- Nitric Oxide
8/3/2019 DVT-Dr Tella (Seminar on DVT)
15/29
Specific methodsSpecific methods
Graduated Elastic stockings:
- Improved venous flow, useful in non-
trauma patients- Applied pre-op and continuedthroughout hospital stay
- Recommended as adjunct in moderateand high risk case
- Must be properly fitted and remain inplace
- Contraindicated in limb ischaemia
8/3/2019 DVT-Dr Tella (Seminar on DVT)
16/29
8/3/2019 DVT-Dr Tella (Seminar on DVT)
17/29
Specific methodsSpecific methods
Intermittent Pneumatic CompressionDevices:
- Intermittent regimen that delivers asustained pressure in distal to proximalmanner
- Intermittently inflates and deflatesbags contained within the garment (20-40 mmHg).
8/3/2019 DVT-Dr Tella (Seminar on DVT)
18/29
Intermittent PneumaticIntermittent Pneumatic
Compression DevicesCompression Devices- Cycle times vary from manufacturer tomanufacturer.
- Typically, the inflation (compression) cycleis 10-15 seconds with a 45-50 secondrelaxation (rest)
8/3/2019 DVT-Dr Tella (Seminar on DVT)
19/29
Intermittent PneumaticIntermittent Pneumatic
Compression DevicesCompression DevicesDirect pumping effect help reduce stasis
Promotes clearance of local pro-
thrombotic factors and increase localplasminogen activators
Doubtful efficacy in obese individuals
Only effective when used continouslyPresumed additive prophylactic effect pharmacologic
8/3/2019 DVT-Dr Tella (Seminar on DVT)
20/29
Wide variety of devices
8/3/2019 DVT-Dr Tella (Seminar on DVT)
21/29
Pneumatic CompressionPneumatic Compression
DevicesDevicesNot recommended as sole agent in:- High risk surgical patients
- Orthopaedics Hip or knee surgery
Method of choice when patient is atincreased risk of bleeding fromanticoagulants
8/3/2019 DVT-Dr Tella (Seminar on DVT)
22/29
VenaVena CavalCaval InterruptionInterruption
Inferior Vena Cavalfilters (IVC filter);
These are mechanicaldevices to trap bloodclots arising from thelower limb, thus
preventing pulmonaryembolism
8/3/2019 DVT-Dr Tella (Seminar on DVT)
23/29
IVC FilterIVC Filter
Current accepted indicationsAbsolute contraindications to
anticoagulant Rx
Life threatening hemorrhage from
anticoagulant Rx
Failure of adequate anticoagulation -recurrence
8/3/2019 DVT-Dr Tella (Seminar on DVT)
24/29
8/3/2019 DVT-Dr Tella (Seminar on DVT)
25/29
Challenges of DVTChallenges of DVT
prophylaxisprophylaxisRoutine assessment of the risk
Perceived diff in risk assessment and risk of
bleeding with anticoagulantEncouragement of routine prophylaxis for ptat risk
Prophylaxis underused Consensus APHA.Mechanical devices are expensive, pt maynot be compliant
8/3/2019 DVT-Dr Tella (Seminar on DVT)
26/29
ACCP RecommendationsACCP Recommendations
Primarily in patients who are at high risk ofbleeding from anticoagulant Rx
Adjunct to anticoagulant-based prophylaxis
Careful attention be directed towards
ensuring the proper use of, and optimalcompliance with the mechanical devices
8/3/2019 DVT-Dr Tella (Seminar on DVT)
27/29
ConclusionConclusionDVT/PE remain important clinical entitiesin hospitalised patients
Risk assessment & re-assessment needto be undertaken on admission andthroughout hospital stay
Non-pharmacological prophylaxis iseffective (as adjunct) in moderate &high-risk surgical patients
8/3/2019 DVT-Dr Tella (Seminar on DVT)
28/29
Thank you
8/3/2019 DVT-Dr Tella (Seminar on DVT)
29/29
ReferencesReferences
Brian Ostrow, Venous Thromboembolism: What Surgeons in lowincome countries need to know - Office of InternationalSurgery, Univ. of Toronto, Canada (www.ptolemy.ca)
David Warwick, A Report of DVT Prophylaxis in Orth.Practice-European Musculoskeletal Review 2007; 48-50
E.A Badoe, E.Q Archampong, J.T da Rocha Afodu,Principlesand practice of Surgery including Pathology in the tropics 3rd
ed; 215-217
M.A.R Al-Fallouji, Postgraduate Surgery: The Candidates
Guide 2nd ed; 368Serdar Toker, david J. Hak & Steven J. Morgan, DVTprophylaxis in Trauma Patients- Review Article, 2011.
Wiley W. Souba, Fink P. Mitchell et al, ACS Surgery:Principles & practice 2007 ed.